The FMBA announced the timing of the appearance of the Russian allergy vaccine

A domestic vaccine against allergy to birch pollen and a number of other sources, which was developed by scientists from the Federal Medical and Biological Agency (FMBA), is scheduled to be registered in late 2025 - early 2026. This was announced on April 10 by Musa Khaitov, Director of the SSC "Institute of Immunology" of the FMBA of Russia, President of the Russian Association of Allergologists and Clinical Immunologists, Corresponding Member of the Russian Academy of Sciences.

"Registration and introduction into civil circulation [of the vaccine] is planned for the end of 2025 — the beginning of 2026," Khaitov said during an open meeting of the Scientific Council of the Russian Academy of Sciences "Life Sciences" devoted to the causes and treatment of allergic diseases in TASS.

He noted that all stages of preclinical studies of the vaccine have been completed successfully. The drug has demonstrated its safety and specific activity. The production regulations for its release have also been developed.

Clinical trials of the vaccine began last year, Khaitov recalled. Now scientists have completed their first phase and are already close to the end of the second. Their results may be published in July-August of this year. In addition, the FMBA is also currently developing a separate ragweed allergy vaccine, which is a common problem in the southern regions of Russia.

In March last year, the chief physician of the Federal State Budgetary Institution "SSC "Institute of Immunology" of the FMBA of Russia, First Vice President, General Director of the Russian Association of Allergologists and Clinical Immunologists (RAAKI), MD, Professor Natalia Ilyina, at a press conference at the Izvestia Medical Center, noted that a domestic vaccine against birch pollen allergy is being developed based on recombinant technologies, jointly with the University of Vienna. The professor noted that, according to scientists' forecasts, it will take from three to five injections to achieve the effect of the vaccine.

On March 13, 2025, Vera Serezhina, an expert doctor at the LabQuest medical company, told Izvestia about ways to deal with spring allergies. According to her, pollinosis occurs in 10-30% of all allergy sufferers and is manifested by tearing, sneezing, nasal congestion, itchy eyes and sometimes even asthma attacks. The main provocateurs of exacerbations are plant pollen and cross—allergens - nuts, spices, honey, herbs and stone fruits like apples.